Not applicableNot Yet RecruitingNCT06585878
What this trial is testing
A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
Who this might be right for
Renal Cell CarcinomaRCCKidney Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60